CV Therapeutics rejects buyout

& Medicaid Services raised issues about the company's Medicare plans, and imposed sanctions on its Medicare plans. " Abbott Laboratories a medical device and drug developer, increased its quarterly dividend by 11% to 40 cents a share, payable May 15. It...